Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$81.41 - $94.33 $1,383 - $1,603
-17 Reduced 6.42%
248 $23.4 Million
Q1 2023

May 10, 2023

SELL
$74.26 - $84.51 $515,215 - $586,330
-6,938 Reduced 96.32%
265 $21.9 Million
Q4 2022

Feb 16, 2023

SELL
$68.3 - $87.44 $15,982 - $20,460
-234 Reduced 3.15%
7,203 $552 Million
Q3 2021

Dec 09, 2021

BUY
$102.91 - $122.75 $1,749 - $2,086
17 Added 0.23%
7,437 $841,000
Q2 2021

Aug 19, 2021

BUY
$83.84 - $104.76 $1,760 - $2,199
21 Added 0.28%
7,420 $825,000
Q1 2021

May 11, 2021

BUY
$78.68 - $90.67 $582,153 - $670,867
7,399 New
7,399 $690,000
Q4 2020

Feb 09, 2021

SELL
$71.69 - $91.23 $513,802 - $653,845
-7,167 Closed
0 $0
Q3 2020

Dec 18, 2020

SELL
$67.19 - $87.44 $13,908 - $18,100
-207 Reduced 2.81%
7,167 $576,000
Q2 2020

Aug 19, 2020

BUY
$57.54 - $76.95 $282,866 - $378,286
4,916 Added 200.0%
7,374 $585,000
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $2,410 - $3,726
46 Added 1.91%
2,458 $534,000
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $1,218 - $1,395
17 Added 0.71%
2,412 $547,000
Q3 2019

Nov 15, 2019

BUY
$61.55 - $75.43 $861 - $1,056
14 Added 0.59%
2,395 $580,000
Q2 2019

Aug 19, 2019

SELL
$55.74 - $64.41 $68,225 - $78,837
-1,224 Reduced 33.95%
2,381 $522,000
Q1 2019

May 16, 2019

BUY
$47.89 - $64.05 $1,436 - $1,921
30 Added 0.84%
3,605 $639,000
Q4 2018

Feb 20, 2019

BUY
$46.41 - $56.94 $3,248 - $3,985
70 Added 2.0%
3,575 $636,000
Q3 2018

Nov 21, 2018

BUY
$45.7 - $58.03 $9,368 - $11,896
205 Added 6.21%
3,505 $524,000
Q2 2018

Aug 16, 2018

BUY
$42.45 - $51.3 $3,183 - $3,847
75 Added 2.33%
3,300 $480,000
Q1 2018

May 16, 2018

BUY
$37.19 - $47.45 $119,937 - $153,026
3,225 New
3,225 $450,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wealth Plan Partners, LLC Portfolio

Follow Wealth Plan Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Plan Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Plan Partners, LLC with notifications on news.